Cargando…

SHAPE-enabled fragment-based ligand discovery for RNA

The transcriptome represents an attractive but underused set of targets for small-molecule ligands. Here, we devise a technology that leverages fragment-based screening and SHAPE-MaP RNA structure probing to discover small-molecule fragments that bind an RNA structure of interest. We identified frag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeller, Meredith J., Favorov, Oleg, Li, Kelin, Nuthanakanti, Ashok, Hussein, Dina, Michaud, Auréliane, Lafontaine, Daniel A., Busan, Steven, Serganov, Alexander, Aubé, Jeffrey, Weeks, Kevin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171761/ https://www.ncbi.nlm.nih.gov/pubmed/35561226 http://dx.doi.org/10.1073/pnas.2122660119

Ejemplares similares

RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP)
por: Siegfried, Nathan A., et al.
Publicado: (2014)

A distinct RNA recognition mechanism governs Np(4) decapping by RppH
por: Levenson-Palmer, Rose, et al.
Publicado: (2022)

Accurate detection of chemical modifications in RNA by mutational profiling (MaP) with ShapeMapper 2
por: Busan, Steven, et al.
Publicado: (2018)

Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Correction: Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP
por: Johansson, Henrik, et al.
Publicado: (2019)

Visualization of RNA structure models within the Integrative Genomics Viewer
por: Busan, Steven, et al.
Publicado: (2017)

ykkC riboswitches employ an add-on helix to adjust specificity for polyanionic ligands
por: Peselis, Alla, et al.
Publicado: (2018)

Functionalized Scout Fragments for Site-Specific Covalent Ligand Discovery and Optimization
por: Crowley, Vincent M., et al.
Publicado: (2021)

Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments
por: Aatkar, Arron, et al.
Publicado: (2023)

Multi-stimuli responsive heterotypic hydrogels based on nucleolipids show selective dye adsorption
por: Nuthanakanti, Ashok, et al.
Publicado: (2020)

Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination
por: Jensen, Owen, et al.
Publicado: (2022)

Fragment-based drug discovery of small molecule ligands for the human chemokine CCL28
por: Zhou, Angela L., et al.
Publicado: (2023)

Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1
por: Luptak, Jakub, et al.
Publicado: (2019)

A Ligand-observed Mass Spectrometry Approach Integrated into the Fragment Based Lead Discovery Pipeline
por: Chen, Xin, et al.
Publicado: (2015)

Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery
por: Chang, Lyra, et al.
Publicado: (2021)

Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination
por: Jensen, Owen, et al.
Publicado: (2022)

Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU)
por: Li, Kelin, et al.
Publicado: (2018)

Structure of the Ribosomal RNA Decoding Site Containing a Selenium‐Modified Responsive Fluorescent Ribonucleoside Probe
por: Nuthanakanti, Ashok, et al.
Publicado: (2017)

Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor
por: Aristotelous, Tonia, et al.
Publicado: (2013)

Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design
por: Magalhães, Joana, et al.
Publicado: (2018)

Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
por: McAulay, Kirsten, et al.
Publicado: (2022)

Direct detection of RNA modifications and structure using single-molecule nanopore sequencing
por: Stephenson, William, et al.
Publicado: (2022)

Enhancing Mucosal-Associated Invariant T Cell Function and Expansion with Human Selective Serum
por: Labuz, Daniel, et al.
Publicado: (2023)

Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
por: Unterlass, Judith E., et al.
Publicado: (2016)

Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines
por: Grainger, Rachel, et al.
Publicado: (2018)

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
por: Konaklieva, Monika I., et al.
Publicado: (2023)

Ligand Binding Induces Agonistic-Like Conformational Adaptations in Helix 12 of Progesterone Receptor Ligand Binding Domain
por: Zheng, Liangzhen, et al.
Publicado: (2019)

Fragments and hot spots in drug discovery
por: Vajda, Sandor, et al.
Publicado: (2015)

Ligand recognition determinants of guanine riboswitches
por: Mulhbacher, Jérôme, et al.
Publicado: (2007)

Discovery of Ligand-Efficient Scaffolds for the Design of Novel Trichomonas vaginalis Uridine Nucleoside Ribohydrolase Inhibitors Using Fragment Screening
por: Auletta, Shannon, et al.
Publicado: (2019)

Crystal polymorphism in fragment-based lead discovery of ligands of the catalytic domain of UGGT, the glycoprotein folding quality control checkpoint
por: Caputo, Alessandro T., et al.
Publicado: (2022)

Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
por: Resnick, Efrat, et al.
Publicado: (2019)

An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor
por: Bhushan, Bhaskar, et al.
Publicado: (2022)

Probing G-quadruplex topologies and recognition concurrently in real time and 3D using a dual-app nucleoside probe
por: Nuthanakanti, Ashok, et al.
Publicado: (2019)

Probing G-quadruplex topologies and recognition concurrently in real time and 3D using a dual-app nucleoside probe
por: Nuthanakanti, Ashok, et al.
Publicado: (2019)

Ligand-binding site prediction of proteins based on known fragment–fragment interactions
por: Kasahara, Kota, et al.
Publicado: (2010)

Fragment-based Shape Signatures: a new tool for virtual screening and drug discovery
por: Zauhar, Randy J., et al.
Publicado: (2013)

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
por: Henderson, Scott H., et al.
Publicado: (2021)

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?
por: Proj, Matic, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fqbhaiqku03k7vjiksvqc43s5a